Filing Details

Accession Number:
0001209191-19-061964
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-26 16:57:39
Reporting Period:
2019-12-23
Accepted Time:
2019-12-26 16:57:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016169 Antares Pharma Inc. ATRS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
901056 Marvin Samson C/O Antares Pharma, Inc.
100 Princeton South, Suite 300
Ewing NJ 08628
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-12-23 150,000 $1.12 201,751 No 4 M Direct
Common Stock Disposition 2019-12-23 150,000 $4.71 51,751 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-12-23 150,000 $0.00 150,000 $1.12
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-06-02 2026-06-01 No 4 M Direct
Footnotes
  1. The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.